Legochem Biosciences Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Legochem Biosciences Inc with three other
miscellaneous service companies in Asia:
Medical Data Vision Co Ltd
sales of 4.03 billion Japanese Yen [US$36.20 million]
of which 62%
was Data profit utilization service),
Seoulin Bioscience Company Limited
(54.41 billion Korean Won [US$44.13 million]
of which 93%
was Biotechnology), and
Medipost Co Ltd
(45.81 billion Korean Won [US$37.15 million]
of which 49%
was Umbilical Cord Blood).
During the year ended December of 2019, sales at
Legochem Biosciences Inc were 57.50 billion Korean Won (US$46.63 million).
increase of 127.8%
versus 2018, when the company's sales were 25.24 billion Korean Won .
This was the fifth consecutive year of sales increases at Legochem Biosciences Inc
(and since 2014, sales have increased a total of 6,509%).